Annual Meeting 2023: Boosting Diversity in Clinical Trials (Part 1, Trial Design)
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
Progress Against Cancer
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
Researchers discover a new way breast density can impact cancer risk, and CAR T-cell therapy remains out of reach...
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
More programs address sexual health in cancer survivors, and survey suggests health insurance often doesn’t cover genetic tumor testing.
People of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
Awareness of HPV link to cancer has declined, and more frequent COVID-19 boosters authorized for people who are immunocompromised.
Researchers use insights from behavioral economics to encourage taking recommended actions in health care.
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of...